Identification of Biomarker May Lead to Earlier Detection of Stomach Cancer

A blood sample may make it easier to detect gastric cancers and could lead to improved treatments for cancers that are resistant to common immunotherapies.

Stomach cancer is the third most common cause of cancer-related deaths in the world, but gaining an accurate diagnosis is not easy. For that reason, gastrointestinal cancers, often caused by dietary and environmental factors, may go undetected for long periods of times.

Juanita Merchant, MD, PhD, is a gastric cancer expert whose research focuses on the molecular mechanisms of the disease.

Currently, diagnosis of stomach or gastric cancer requires the patient to undergo an upper endoscopy, where a doctor looks for signs of cancer and takes a tissue sample for analysis.

University of Arizona Health Sciences researchers discovered a promising new biomarker that appears in patients before stomach cancer develops. The biomarker, which can be identified through a simple blood test, may help with early detection of the disease and could lead to better treatments. Read full story: https://bit.ly/2FUI9JY


Subscribe: https://bit.ly/subscribeUAHS

Follow University of Arizona Health Sciences:
Facebook: https://facebook.com/uazhealthsciences
Instagram: https://instagram.com/uazhealthsciences
Twitter: https://twitter.com/uazhealth

Website: https://www.uahs.arizona.edu/